Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry
Authors' conclusion
T1DX Registry data demonstrate that CGM use follows the inverse care law, with health technology utilization inversely related to disease burden. Federal policies promoting CGM use in Medicare and Medicaid populations can facilitate the ADA's recommendation for patients with insulin-managed diabetes mellitus.
Study context
- Population
- Participants of the T1D Exchange (T1DX) Registry 2016–2018 cohort, most recent cross-sectionT1DX Registry
- Participants
- 22,418 participants
- Exposure
- Socioeconomic and demographic factors associated with continuous glucose monitoring (CGM) use
- Outcome
- CGM use (yes/no)
Methodological detailsregistry-based, binomial logistic regression
- Registry-based
- Binomial logistic regression
Main finding
As reported in the abstract
Odds of CGM use
Odds ratio (CI)P value
Black Non-Hispanicvs White Non-Hispanic
0.45(0.36–0.57)
P < 0.001American Indian/Alaskan Nativevs White Non-Hispanic
0.33(0.14–0.70)
P = 0.008Government insurancevs Private insurance
0.59(0.52–0.66)
P < 0.001$100,000 or morevs <$25,000
2.06(1.75–2.45)
P < 0.001Observational data: associations, not effects.
Further findings
| Outcome | OR (CI) | P value | |
|---|---|---|---|
| CGM use, subgroup by income bracket: government insured earning <$25,000 annuallyvs private insuranceIncome <$25,000; least likely to use CGMs | 0.44 (0.32–0.61) | P < 0.001 | |
| 0.20.5125Odds ratio (log scale) |
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry. J Diabetes Sci Technol. Published 3 May 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →